POSCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
POSITRON CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.70+0.15 (+9.68%)
Close on Oct 19, 2026
- Market cap
- $55.84M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.32 (+22.85%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
POSITRON CORP saw revenue fall 21.5% to $461.45K over fiscal 2025.
Revenue
$461.45K
-21.5% vs. a year earlier
Operating income
-$10.50M
FY2025
EPS, diluted
-$0.34
FY2025
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $55.84M
- P/E ratio
- –
- Price to sales
- 121.02
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $461.45K
- Net income
- -$10.60M
- EPS, diluted
- -$0.34
- Book value per share
- -$0.02
- Diluted shares
- 33M
Nine years at a glance
Fiscal years 2009 to 2025, USD
Revenue
$461.45K-21.5% YoY
Gross profit
-$2.11M
Operating income
-$10.50M
Net income
-$10.60M
EPS, diluted
-$0.34
Free cash flow
–
Reported period